These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21257797)

  • 21. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing departure from dose linearity under a repeated measures incomplete block design.
    Cheng B; Chow SC
    Pharm Stat; 2011; 10(4):357-62. PubMed ID: 21104786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mixture model with random-effects components for clustering correlated gene-expression profiles.
    Ng SK; McLachlan GJ; Wang K; Ben-Tovim Jones L; Ng SW
    Bioinformatics; 2006 Jul; 22(14):1745-52. PubMed ID: 16675467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-drug interaction prediction assessment.
    Zhou J; Qin Z; Sara QK; Kim S; Wang Z; Hall SD; Li L
    J Biopharm Stat; 2009 Jul; 19(4):641-57. PubMed ID: 20183431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human.
    Lombardo F; Obach RS; Dicapua FM; Bakken GA; Lu J; Potter DM; Gao F; Miller MD; Zhang Y
    J Med Chem; 2006 Apr; 49(7):2262-7. PubMed ID: 16570922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost of checking proportional hazards.
    Shepherd BE
    Stat Med; 2008 Apr; 27(8):1248-60. PubMed ID: 17708517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation.
    Baklouti S; Comets E; Gandia P; Concordet D
    Clin Pharmacokinet; 2023 Nov; 62(11):1599-1609. PubMed ID: 37717242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.
    Ogungbenro K; Aarons L; Graham G
    J Biopharm Stat; 2006; 16(2):135-50. PubMed ID: 16584063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance descriptors: analysis and evaluation in terms of therapeutic effect.
    Sarem S; Li J; Nekka F
    Biopharm Drug Dispos; 2011 Mar; 32(2):76-88. PubMed ID: 21341277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simulation study to assess statistical methods for binary repeated measures data.
    Masaoud E; Stryhn H
    Prev Vet Med; 2010 Feb; 93(2-3):81-97. PubMed ID: 20004989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the coefficient of determination (r2) in assessing the accuracy of interspecies allometric predictions: illumination or illusion?
    Tang H; Mayersohn M
    Drug Metab Dispos; 2007 Dec; 35(12):2139-42. PubMed ID: 17761780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.
    Silber HE; Kjellsson MC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2009 Feb; 36(1):81-99. PubMed ID: 19219538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractal Kinetic Implementation in Population Pharmacokinetic Modeling.
    Jung W; Ryu HJ; Chae JW; Yun HY
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
    Hooker AC; Staatz CE; Karlsson MO
    Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models.
    Jamsen KM; Patel K; Nieforth K; Kirkpatrick CMJ
    CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):678-686. PubMed ID: 30058222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.